NCT02023541

Proton Beam Therapy to Treat Esophageal Cancer

A Phase I Study of Proton Beam Therapy in the Treatment of Esophageal Cancer

• Status: Terminated
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 3 (actual)
• Sponsor: Washington University School of Medicine · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Assess progression-free survival and overall survival of proton beam therapy (PBT) for patients with resectable vs. unresectable esophageal cancer, and to assess patient-reported outcomes of PBT for esophageal cancer at 6 months following chemoradiation and physician-reported toxicity of PBT for esophageal cancer.

Conditions

• Esophageal Squamous Cell Carcinoma
• Adenocarcinoma Of Esophagus

Interventions

Type	Name	Description
RADIATION	Proton beam therapy

Timeline

• Start date: 2014-01-01
• Primary completion: 2015-04-01
• Completion: 2015-04-01
• First posted: 2013-12-30
• Last updated: 2015-04-07

Locations

1 site across 1 country: United States